Target Price | $30.27 |
Price | $25.73 |
Potential |
17.66%
register free of charge
|
Number of Estimates | 11 |
11 Analysts have issued a price target IMAX Corporation 2026 .
The average IMAX Corporation target price is $30.27.
This is
17.66%
register free of charge
$36.00
39.91%
register free of charge
$16.00
37.82%
register free of charge
|
|
A rating was issued by 11 analysts: 9 Analysts recommend IMAX Corporation to buy, 1 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the IMAX Corporation stock has an average upside potential 2026 of
17.66%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 352.21 | 406.01 |
6.04% | 15.28% | |
EBITDA Margin | 33.59% | 39.01% |
8.65% | 16.12% | |
Net Margin | 7.22% | 11.83% |
11.05% | 63.94% |
11 Analysts have issued a sales forecast IMAX Corporation 2025 . The average IMAX Corporation sales estimate is
This results in the following potential growth metrics:
11 Analysts have issued an IMAX Corporation EBITDA forecast 2025. The average IMAX Corporation EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 IMAX Corporation Analysts have issued a net profit forecast 2025. The average IMAX Corporation net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 0.48 | 0.91 |
4.35% | 89.58% | |
P/E | 28.38 | |
EV/Sales | 3.99 |
7 Analysts have issued a IMAX Corporation forecast for earnings per share. The average IMAX Corporation EPS is
This results in the following potential growth metrics and future valuations:
IMAX Corporation...
Analyst | Rating | Action | Date |
---|---|---|---|
JP Morgan |
Locked
➜
Locked
|
Locked | Feb 21 2025 |
Wells Fargo |
Locked
➜
Locked
|
Locked | Feb 20 2025 |
Benchmark |
Locked
➜
Locked
|
Locked | Feb 20 2025 |
Macquarie |
Locked
➜
Locked
|
Locked | Feb 20 2025 |
Barrington Research |
Locked
➜
Locked
|
Locked | Feb 20 2025 |
Rosenblatt |
Locked
➜
Locked
|
Locked | Feb 20 2025 |
Wedbush |
Locked
➜
Locked
|
Locked | Feb 12 2025 |
Analyst Rating | Date |
---|---|
Locked
JP Morgan:
Locked
➜
Locked
|
Feb 21 2025 |
Locked
Wells Fargo:
Locked
➜
Locked
|
Feb 20 2025 |
Locked
Benchmark:
Locked
➜
Locked
|
Feb 20 2025 |
Locked
Macquarie:
Locked
➜
Locked
|
Feb 20 2025 |
Locked
Barrington Research:
Locked
➜
Locked
|
Feb 20 2025 |
Locked
Rosenblatt:
Locked
➜
Locked
|
Feb 20 2025 |
Locked
Wedbush:
Locked
➜
Locked
|
Feb 12 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.